Cerebral microbleeds and age-related macular degeneration: the AGES-Reykjavik Study.

Kleins Lab // Publications // Dec 01 2012

PubMed ID: 22382405

Author(s): Qiu C, Cotch MF, Sigurdsson S, Eiriksdottir G, Jonasson F, Klein R, Klein BE, Harris TB, van Buchem MA, Gudnason V, Launer LJ. Cerebral microbleeds and age-related macular degeneration: the AGES-Reykjavik Study. Neurobiol Aging. 2012 Dec;33(12):2935-7. doi: 10.1016/j.neurobiolaging.2012.01.012. Epub 2012 Mar 3. PMID 22382405

Journal: Neurobiology Of Aging, Volume 33, Issue 12, Dec 2012

We test the hypothesis that cerebral microbleeds (CMB) and age-related macular degeneration (AMD), both linked to amyloid-β deposition, are correlated. This study includes 4205 participants (mean age 76.2; 57.8% women) in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study (2002-2006). CMB were assessed from magnetic resonance images, and AMD was assessed using digital retinal images. Data were analyzed with multinomial logistic models controlling for major confounders. Evidence of CMB was detected in 476 persons (272 with strict lobar CMB and 204 with nonlobar CMB). AMD was detected in 1098 persons (869 with early AMD, 140 with exudative AMD, and 89 with pure geographic atrophy). Early and exudative AMD were not associated with CMB. The adjusted odds ratio of pure geographic atrophy was 1.62 (95% confidence interval 0.93-2.82, p = 0.089) for having any CMB, 1.43 (0.66-3.06, p = 0.363) for strict lobar CMB, and 1.85 (0.89-3.87, p = 0.100) for nonlobar CMB. This study provides no evidence that amyloid deposits in the brain and AMD are correlated. However, the suggestive association of geographic atrophy with CMB warrants further investigation.

Copyright © 2012 Elsevier Inc. All rights reserved.